Process Evaluation of Quality in the Diagnosis and Treatment of Tuberculosis in Public Health Facilies of Southwes Ethiopia: Cross Sectional Study

Year 2016, Volume: 6 Issue: 4, 156 - 162, 01.12.2016

Dawit Logita, Dessalegn Dabaro

https://doi.org/10.5799/jmid.vi.328861

Cited By: 1

Abstract

Background: Even though Ethiopia has implemented the Directly Observed Treatment Short (DOTS) service for a long
time, the national targets of Tuberculosis (TB) control were not achieved yet. Like the country wide, the Kersa district
shares the same problem, and also TB control program have never been evaluated in this district.
Methods: Process evaluation was conducted based on Donabedian’s structure-process-outcome model of health care
quality. Facility based cross-sectional study design was employed. Four, tuberculosis directly observed short course
therapy providing health centers were selected. Medical records of TB suspects and patients were reviewed. Ongoing
laboratory practice and patient provider interaction was observed.
Results: The resources recommended by national tuberculosis control program for diagnosis and treatment were available,
except a shortage of paediatric dose of TB drug and Acid Fast Bacilli (AFB) reagents. Only 64.8% of TB suspects
received sputum smear laboratory examination, and 52.7% of TB patients received the right doses of treatment.
Conclusion: The shortage of drugs and reagents and, low uptake of microscopic AFB examination service was the main
constraints of service. Adequate and continuous resource supply and regular and continuous monitoring of diagnosis
and treatment process should be considered. J Microbiol Infect Dis 2016;6(4): 156-162  

Keywords

Quality, evaluation, program, Tuberculosis

References

• 1. WHO/HTM/TB. WHO report 2011: Global tuberculosis control. In. Geneva, Switzerland: World Health Organization; 2011.
• 2. France T (ed.), The Global Plan To Stop TB 2011-15: Transforming the fight toward elimination of tuberculosis. Geneva, Switzerland: World Health Organization 2011.
• 3. Federal Ministry of Health Ethiopia: Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual, Fourth edn. Addis Ababa, Ethiopia; 2008.
• 4. WHO/HTM/TB: WHO Report 2010. Global Tuberculosis Control. Geneva, Switzerland: WHO; 2010.
• 5. Makombe R: Special Summit of African Union on HIV/AIDS, Tuberculosis and Malaria (ATM). Abuja, Nigeria; 2006.
• 6. Karsa District Health Office, District Health Office Report 2010/11.
• 7. Zonal Performance Report 2010/11. Jimma Zone Tuberculosis Control. Jimma Zone Health Department; 2011.
• 8. Assefa A, Kassa M, Tadese G. Therapeutic efficacy of Artemether/Lumefantrine (Coartem) againist Plasmodium falciparium in Kersa, South West Ethiopia Parasite A & Vectors 2010, 3:1.
• 9. Donabedian A: Introduction to Quality Assurance in Health Care, First edn. New York: Oxford University; 2003.
• 10. WHO/HTM/TB. Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs. Geneva, Switzerland: World Health Organization; 2004.
• 11. Mesfin MM, Newell JN, Walley JD, et al. Quality of TB care and its association with patient adherence to treatment in eight Ethiopial district. Oxford Unversity Press 2009, 24:457- 466.
• 12. José FM, Karen P, Mario RDP, Leopold B, Karin B, Mario R: The health workforce crisis in TB control: a report from highburden countries. In. Geneva, Switzerland; 2005.
• 13. Jaggarajamma K, Sudha G, Chandrasekaran V, et al. Reasons for non-compliance among patients treated under revised national tuberculosis control programme (rNTP), tiruvallur district, south India. Indian J Tuberc 2007, 54:130-135.
• 14. Saukkonen JJ, Cohn DL: An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. American Thoracic Society 2006, 174:935-952.
• 15. Dembele SM, Ouedraogo HZ, Combary A, Saleri N, Macq J, Dujardin B. Conversion rates at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso. Int J Tuberc Lung Dis 2007, 11:1339-1344.
• 16. Xua B, Fochsen BG, Xiua BY, Thorson BA, Kempc JR, Jiang QW. Perceptions and experiences of health care seeking and access to TB care. Fudan University, Shanghai, China 2004:139-149.
• 17. Jeremiah S, Benson R, Emmanuel O. Low sputum smear positive tuberculosis among pulmonary tuberculosis suspects in a tertiary hospital in Mwanza, Tanzania. Tanzania J Health Res 2011, 14(2).
• 18. Tahir M, Sharma SK, Rohrberg DS, Gupta D, Singh UB, Sinha PK. DOTS at a tertiary care center in northern India. Indian J Med Res 2006, 123:702-706.
• 19. Yassin MA, Cuevas LE. How many sputum smears are necessary for case finding in pulmonary tuberculosis? Trop Med Intern Health 2003, 8 (10):927-932.
• 20. Muvunyi CM, Masaisa F, Bayingana C, Musemakweri A, Mutesa L, Hernandez TC: Prevalence and diagnostic aspects of sputum smear positive tuberculosis cases at a tertiary care institution in Rwanda. African J Microbiol Res 2010, 4(1):088-091.